Imaging in gynecological disease (16): clinical and ultrasound characteristics of serous cystadenofibromas in adnexa.


Journal

Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology
ISSN: 1469-0705
Titre abrégé: Ultrasound Obstet Gynecol
Pays: England
ID NLM: 9108340

Informations de publication

Date de publication:
Dec 2019
Historique:
received: 07 12 2018
revised: 19 02 2019
accepted: 23 03 2019
pubmed: 3 4 2019
medline: 6 5 2020
entrez: 3 4 2019
Statut: ppublish

Résumé

To describe the clinical and ultrasound characteristics of serous cystadenofibromas in the adnexa. This was a retrospective study of patients identified in the International Ovarian Tumor Analysis (IOTA) database, who had a histological diagnosis of serous cystadenofibroma and had undergone preoperative ultrasound examination by an experienced ultrasound examiner, between 1999 and 2012. In the IOTA database, which contains data collected prospectively, the tumors were described using the terms and definitions of the IOTA group. In addition, three authors reviewed, first independently and then together, ultrasound images of serous cystadenofibromas and described them using pattern recognition. We identified 233 women with a histological diagnosis of serous cystadenofibroma. In the IOTA database, most cystadenofibromas (67.4%; 157/233) were described as containing solid components but 19.3% (45/233) were described as multilocular cysts and 13.3% (31/233) as unilocular cysts. Papillary projections were described in 52.4% (122/233) of the cystadenofibromas. In 79.5% (97/122) of the cysts with papillary projections, color Doppler signals were absent in the papillary projections. Most cystadenofibromas (83.7%; 195/233) manifested no or minimal color Doppler signals. On retrospective analysis of 201 ultrasound images of serous cystadenofibromas, using pattern recognition, 10 major types of ultrasound appearance were identified. The most common pattern was a unilocular solid cyst with one or more papillary projections, but no other solid components (25.9%; 52/201). The second most common pattern was a multilocular solid mass with small solid component(s), but no papillary projections (19.4%; 39/201). The third and fourth most common patterns were multi- or bilocular cyst (16.9%; 34/201) and unilocular cyst (11.9%; 24/201). Using pattern recognition, shadowing was identified in 39.8% (80/201) of the tumors, and microcystic appearance of the papillary projections was observed in 34 (38.6%) of the 88 tumors containing papillary projections. The ultrasound features of serous cystadenofibromas vary. The most common pattern is a unilocular solid cyst with one or more papillary projections but no other solid components, with absent color Doppler signals. Most serous cystadenofibromas were poorly vascularized on color Doppler examination and many manifested acoustic shadowing. Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

Identifiants

pubmed: 30937992
doi: 10.1002/uog.20277
doi:

Types de publication

Comparative Study Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

823-830

Informations de copyright

Copyright © 2019 ISUOG. Published by John Wiley & Sons Ltd.

Références

Scully RE. World Health Organization. International Histological Classification of Tumours: Histological Typing of Ovarian Tumours (2nd edn). Springer: Berlin, Heidelberg, 1999.
Kurman RJ, Ellenson LH, Ronnett BM. Surface epithelial tumors of the ovary. In Blaustein's pathology of the female genital tract (6th edn). Springer: New York, NY, 2011: 703-758.
Fatum M, Rojansky N, Shushan A. Papillary serous cystadenofibromas of the ovary: is it really so rare? Int J Gynaecol Obstet 2001; 75: 85-86.
Seidman JD. Benign ovarian serous tumors: a re-evaluation and proposed reclassification of serous “cystadenomas” and “cystadenofibromas”. Gynecol Oncol 2005; 96: 395-401.
Czernobilsky B, Borenstein R, Lancet M. Cystadenofibroma of the ovary. Cancer 1974; 34: 1971-1981.
De Silva TS, Patil A, Lawrence RN. Acute presentation of a benign cystadenofibroma of the fallopian tube: a case report. J Med Case Rep 2010; 4: 181.
Groutz A, Wolman I, Wolf Y, Luxman D, Sagi J, Jaffa AJ, David MP. Cystadenofibroma of the ovary in young women. Eur J Obstet Gynecol Reprod Biol 1994; 54: 137-139.
Shimizu S, Okano H, Ishitani K, Nomura H, Nishikawa T, Ohta H. Ovarian cystadenofibroma with solid nodular components masqueraded as ovarian cancer. Arch Gynecol Obstet 2009; 279: 709-711.
Kim KA, Park CM, Lee JH, Kim HK, Cho SM, Kim B, Seol HY. Benign ovarian tumors with solid and cystic components that mimic malignancy. AJR Am J Roentgenol 2004; 182: 1259-1265.
Timmerman D, Testa AC, Bourne T, Ferrazzi E, Ameye L, Konstantinovic ML, Valentin L. Logistic regression model to distinguish between the benign and malignant adnexal mass before surgery: a multicenter study by the International Ovarian Tumor Analysis Group. J Clin Oncol 2005; 23: 8794-8801.
Van Holsbeke C, Van Calster B, Testa AC, Domali E, Lu C, Van Huffel S, Valentin L, Timmerman D. Prospective internal validation of mathematical models to predict malignancy in adnexal masses: results from international ovarian tumor analysis study. Clin Cancer Res 2009; 15: 684-681.
Timmerman D, Van Calster B, Testa AC, Guerriero S, Fischerova D, Lissoni AA, Valentin L. Ovarian cancer prediction in adnexal masses using ultrasound-based logistic regression models: a temporal and external validation study by the IOTA group. Ultrasound Obstet Gynecol 2010; 36: 226-234.
Testa A, Kaijser J, Wynants L, Fischerova D, Van Holsbeke C, Franchi D, Savelli L, Epstein E, Czekierdowski A, Guerriero S, Timmerman D. Strategies to diagnose ovarian cancer: New evidence from phase 3 of the multicentre international IOTA study. Br J Cancer 2014; 111: 680-688.
Timmerman D, Valentin L, Bourne TH, Collins WP, Verrelst H, Vergote I. Terms, definitions and measurements to describe the sonographic features of adnexal tumors: a consensus opinion from the International Ovarian Tumor Analysis (IOTA) Group. Ultrasound Obstet Gynecol 2000; 16: 500-505.
Valentin L. Pattern recognition of pelvic masses by gray-scale ultrasound imaging: the contribution of Doppler ultrasound. Ultrasound Obstet Gynecol 1999; 14: 338-347.
Longacre TA, Wells M. Serous tumors. In WHO Classification of Tumours of Female Reproductive Organs (4th edn), Kurman RJ, Carcangiu ML, Herrington CS, Young RH (eds). IARC, Lyon, 2014: 17.
Alcazar JL, Errasti T, Minguez JA, Galan MJ, Garcia-Manero M and Ceamanos C. Sonographic features of ovarian cystadenofibromas: spectrum of findings. J Ultrasound Med 2001; 20: 915-919.
Goldstein SR, Timor-Tritsch IE, Monteagudo A, Monda S, Popiolek D. Cystadenofibromas: can transvaginal ultrasound appearance reduce some surgical interventions? J Clin Ultrasound 2015; 43: 393-396.
Goldstein SR, Timor-Tritsch I, Monda S, Popliolek D, Monteagudo A. OC25.03: Ultrasound appearance of cystadenofibroma: can we reduce surgical intervention? Ultrasound Obstet Gynecol 2009; 34 suppl 1: 49.
Ludovisi M, Foo X, Mainenti S, Testa AC, Arora R, Jurkovic D. Ultrasound diagnosis of serous surface papillary borderline ovarian tumor: A case series with a review of the literature. J Clin Ultrasound 2015; 43: 573-577.
Valentin L, Ameye L, Jurkovic D, Metzger U, Lécuru F, Sabine Van Huffel S, Timmerman D. Which extrauterine pelvic masses are difficult to correctly classify as benign or malignant on the basis of ultrasound findings, and is there a way of making a correct diagnosis? Ultrasound Obstet Gynecol 2006; 27: 438-444.
Valentin L, Ameye L, Savelli L, Fruscio R, Leone FP, Czekierdowski A, Lissoni AA, Fischerova D, Guerriero S, Van Holsbeke C, Van Huffel S, Timmerman D. Adnexal masses difficult to classify as benign or malignant using subjective assessment of gray-scale and Doppler ultrasound findings: logistic regression models do not help. Ultrasound Obstet Gynecol 2011; 38: 456-465.
Valentin L, Ameye L, Savelli L, Fruscio R, Leone FP, Czekierdowski A, Lissoni AA, Fischerova D, Guerriero S, Van Holsbeke C, Van Huffel S, Timmerman D. Unilocular adnexal cysts with papillary projections but no other solid components: is there a diagnostic method that can classify them reliably as benign or malignant before surgery? Ultrasound Obstet Gynecol 2013; 41: 570-581.
Landolfo C, Valentin L, Franchi D, Van Holsbeke C, Fruscio R, Froyman W, Sladkevicius P, Kaijser J, Ameye L, Bourne T, Savelli L, Coosemans A, Testa A, Timmerman D. Differences in ultrasound features of papillations in unilocular-solid adnexal cysts: a retrospective international multicenter study. Ultrasound Obstet Gynecol 2018; 52: 269-278.
Timor-Tritsch IE, Foley CE, Brandon C, Yoon E, Ciaffarrano J, Monteagudo A, Mittal K, Boyd L. New sonographic marker of borderline ovarian tumor: microcystic pattern of papillae and solid components. Ultrasound Obstet Gynecol 2019; 54: 395-402.

Auteurs

B A Virgilio (BA)

Istituto di Ginecologia ed Ostetricia, Università Cattolica del Sacro Cuore, Rome, Italy.
Department of Obstetrics and Gynecology, Policlinico Hospital, Abano Terme, Padua, Italy.

I De Blasis (I)

Istituto di Ginecologia ed Ostetricia, Università Cattolica del Sacro Cuore, Rome, Italy.

P Sladkevicius (P)

Department of Obstetrics and Gynecology, Skåne University Hospital, Malmö, Sweden.

F Moro (F)

Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

G F Zannoni (GF)

Dipartimento Scienze della Salute della Donna e del Bambino, Unità di Ginecopatologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

D Arciuolo (D)

Dipartimento Scienze della Salute della Donna e del Bambino, Unità di Ginecopatologia, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

F Mascilini (F)

Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

F Ciccarone (F)

Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

D Timmerman (D)

Department of Obstetrics and Gynecology, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium.

J Kaijser (J)

Department of Obstetrics and Gynecology, University Hospitals, Katholieke Universiteit Leuven, Leuven, Belgium.

R Fruscio (R)

Clinic of Obstetrics and Gynecology, Department of Medicine and Surgery, San Gerardo Hospital, University of Milan-Bicocca, Monza, Italy.

C Van Holsbeke (C)

Department of Obstetrics and Gynecology, Ziekenhuis Oost-Limburg, Genk, Belgium.

D Franchi (D)

Preventive Gynecology Unit, Division of Gynecology, European Institute of Oncology, IRCCS, Milan, Italy.

E Epstein (E)

Department of Clinical Science and Education, Karolinska Institutet, Stockholm, Sweden.
Department of Obstetrics and Gynecology, Södersjukhuset, Stockholm, Sweden.

F P G Leone (FPG)

Department of Obstetrics and Gynecology, Clinical Sciences Institute, L. Sacco, Milan, Italy.

S Guerriero (S)

Department of Obstetrics and Gynecology, University of Cagliari, Policlinico Universitario Duilio Casula, Monserrato, Cagliari, Italy.

A Czekierdowski (A)

First Department of Gynecological Oncology and Gynecology, Medical University of Lublin, Lublin, Poland.

G Scambia (G)

Dipartimento Scienze della Salute della Donna, del Bambino e di Sanità Pubblica, Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

A C Testa (AC)

Istituto di Ginecologia ed Ostetricia, Università Cattolica del Sacro Cuore, Rome, Italy.
Fondazione Policlinico Universitario A. Gemelli, IRCCS, Rome, Italy.

L Valentin (L)

Department of Obstetrics and Gynecology, Skåne University Hospital, Malmö, Sweden.
Institution of Clinical Sciences Malmö, Lund University, Lund, Sweden.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH